Stock listing

Dusseldorf:49Z BICO Group AB Aktie

German listing (Dusseldorf) of BICO Group AB · home listing Stockholm:BICO

Follow BICO Group AB into a list and get an email when it puts out news.

Share price · DUS:49Z

€1.31 EUR -0.11 (-7.5%)

Close on Nov 20, 2026

Past year -10.0% · daily closes, Nov 20, 2025 – Nov 12, 2026, adjusted for splits
Day range
€1.31 – €1.40 EURNov 20, 2026
Market cap
€992.3M EURAt the close on Nov 20, 2026 · price × 759.8M shares outstanding
52-week range
€1.18 – €2.30 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€1 EURMedian day 0 shares · 60 days with no trades · last 3 months, Aug 20, 2026 – Nov 12, 2026
BICO Group AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:BICO · Home15.18 SEK-1.12 (-6.9%)321,04715.7815.7815.1616.30Close on Nov 20, 2026
Frankfurt:49Z€1.374 EUR-0.082 (-5.6%)1,500€1.40€1.406€1.374€1.456Close on Nov 20, 2026
OTC:CLLKF$1.471 USD-1.071 (-42.1%)320$1.471$1.471$1.471$2.543Close on Nov 20, 2026
Dusseldorf:49Z€1.306 EUR-0.106 (-7.5%)—€1.40€1.40€1.306€1.412Close on Nov 20, 2026
OTC:BCCOY$0.46 USD-0.017 (-3.6%)200$0.46$0.46$0.46$0.477Close on Nov 19, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 12, 2026 · DUS:49Z · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€1.489-0.78-34.4%€1.539€1.559€1.4860
€2.269+0.037+1.7%€2.269€2.269€2.2690
€2.232+0.072+3.3%€2.185€2.248€2.1760
€2.16-0.027-1.2%€2.179€2.235€2.1410
€2.187-0.02-0.9%€2.197€2.207€2.1840
€2.207+0.019+0.9%€2.149€2.295€2.1480
€2.188+0.078+3.7%€2.104€2.19€2.0960
€2.11-0.095-4.3%€2.139€2.169€2.060
€2.205+0.0010.0%€2.228€2.228€2.1860
€2.204+0.0010.0%€2.096€2.224€2.0950
€2.203+0.042+1.9%€2.201€2.214€2.1990
€2.161-0.011-0.5%€2.171€2.21€2.1560
€2.172+0.009+0.4%€2.164€2.21€2.1610
€2.163+0.02+0.9%€2.18€2.185€2.1320
€2.143+0.0010.0%€2.146€2.175€2.1430
€2.142-0.011-0.5%€2.134€2.197€2.120
€2.153-0.009-0.4%€2.154€2.154€2.150
€2.162+0.006+0.3%€2.16€2.168€2.1210
€2.156-0.015-0.7%€2.16€2.175€2.1470
€2.171+0.014+0.6%€2.171€2.229€2.16740
€2.157-0.058-2.6%€2.164€2.172€2.1390
€2.215-0.013-0.6%€2.217€2.256€2.2040
€2.228+0.116+5.5%€2.134€2.244€2.1310
€2.112+0.069+3.4%€2.056€2.146€2.0560
€2.043+0.091+4.7%€1.989€2.141€1.9740
€1.952+0.023+1.2%€1.902€1.962€1.8960
€1.9290.000.0%€1.924€1.93€1.9060
€1.929-0.037-1.9%€1.982€2.045€1.9270
€1.966-0.001-0.1%€1.978€1.978€1.9560
€1.967+0.057+3.0%€1.889€1.971€1.8860
€1.91+0.01+0.5%€1.917€1.931€1.8730
€1.90+0.018+1.0%€1.895€1.961€1.8920
€1.882-0.068-3.5%€1.932€1.971€1.8820
€1.95+0.003+0.2%€1.962€1.97€1.9210
€1.947-0.028-1.4%€1.958€1.967€1.9470
€1.975+0.004+0.2%€1.978€1.981€1.9750
€1.971+0.011+0.6%€1.97€1.971€1.970
€1.96+0.02+1.0%€1.925€1.96€1.9060
€1.94-0.031-1.6%€1.97€1.993€1.9370
€1.971-0.01-0.5%€1.979€2.024€1.9490
€1.981+0.077+4.0%€1.907€1.989€1.9040
€1.904+0.081+4.4%€1.833€1.93€1.8180
€1.823-0.004-0.2%€1.833€1.856€1.7980
€1.827+0.004+0.2%€1.799€1.855€1.7960
€1.8230.000.0%€1.831€1.851€1.8030
€1.823-0.06-3.2%€1.859€1.868€1.8150
€1.883-0.008-0.4%€1.874€1.908€1.8740
€1.891-0.075-3.8%€1.957€1.959€1.8850
€1.966-0.003-0.2%€1.966€1.966€1.9660
€1.969-0.022-1.1%€1.99€2.004€1.9590
€1.991-0.006-0.3%€2.024€2.051€1.9760
€1.997+0.038+1.9%€1.953€2.055€1.9520
€1.959+0.02+1.0%€1.971€2.035€1.9560
€1.939+0.078+4.2%€1.892€1.977€1.8910
€1.861+0.078+4.4%€1.815€1.885€1.8040
€1.783-0.007-0.4%€1.783€1.808€1.7670
€1.79-0.009-0.5%€1.809€1.825€1.7780
€1.799-0.009-0.5%€1.81€1.83€1.7830
€1.808+0.022+1.2%€1.778€1.885€1.7740
€1.786+0.069+4.0%€1.75€1.787€1.6870
€1.717+0.001+0.1%€1.679€1.766€1.6680
Ticker
Dusseldorf:49Z
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Dusseldorf
Currency
EUR

What changed lately

Latest news

All BICO Group AB news

BICO Group AB on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
15 in the last 12 months · 15 in all · newest Aug 19, 2026 · oldest 2025
Calls
10 calls with a replay · 10 with a transcript · latest Aug 19, 2026
Decks
22 decks · latest Nov 11, 2026

Where BICO Group AB is listed

ListingExchangeCountryCurrency
Stockholm:BICO · Home listingStockholmSwedenSEK
Tradegate:49ZTradegateGermanyEUR
gettex:49ZgettexGermanyEUR
Frankfurt:49ZFrankfurtGermanyEUR
Lang & Schwarz:A2PX00Lang & SchwarzGermanyEUR
LS Exchange:A2PX00LS ExchangeGermanyEUR
OTC:CLLKFOTCUnited StatesUSD
Stuttgart:49ZStuttgartGermanyEUR
Dusseldorf:49Z · This pageDusseldorfGermanyEUR
OTC:BCCOYOTCUnited StatesUSD
Aquis:BICOSAquisUnited KingdomSEK
Aquis:BICOSAquisUnited KingdomSEK
Turquoise:BICOSTurquoiseUnited KingdomSEK
Hamburg:49ZHamburgGermanyEUR
Munich:49ZMunichGermanyEUR
Hanover:49ZHanoverGermanyEUR
Xetra:49ZXetraGermanyEUR

Valuation

EV/sales 0.6× against a median of 1.3×: 2nd lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Aug 31, 2026 · price Nov 20, 2026

Enterprise value
924.2M SEK
P/E
Loss
EV/sales
0.6×
EV/EBITDA
2.1×
Price/book
0.8×
Gross margin
52.1%
Operating margin
−5.0%
Net margin
−28.3%
Debt to equity
0.3×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
BICO Group AB Class B · OMXSTO:BICOUS$102.7MUS$90.50Mn/a0.6×2.1×0.8×−28.3%0.3×n/a
Fine Foods & Pharmaceuticals N.T.M. SpA · MIL:FFUS$123.5MUS$174.6M11.1×0.6×4.6×0.8×4.0%0.6×n/a
Burning Rock Biotech Ltd. · NASDAQ:BNRUS$116.7MUS$60.54Mn/a0.8×n/a1.6×−13.6%0.1×1.51
BIODYNE Co., Ltd. · KRX:314930US$115.0MUS$104.0M182×19.9×70.7×3.5×12.1%0.0×n/a
Photocure ASA · OSL:PHOUS$113.9MUS$97.23M22.9×1.4×6.1×1.9×7.1%0.0×n/a
ArcticZymes Technologies ASA · OSL:AZTUS$108.4MUS$80.84M66.1×6.2×24.6×3.0×12.7%0.0×n/a
NanoenTek, Inc. · KRX:039860US$107.8MUS$71.26M24.8×2.2×17.4×1.5×13.3%0.0×n/a
Devyser Diagnostics AB · OMXSTO:DVYSRUS$99.24MUS$94.86M39.9×3.8×17.5×2.6×10.0%0.1×n/a
Quanterix Corporation · NASDAQ:QTRXUS$93.06MUS$47.06Mn/a0.3×n/a0.4×−75.0%0.1×1.87
Exagen Inc. · NASDAQ:XGNUS$92.10MUS$86.82Mn/a1.2×n/a6.7×−25.1%1.7×2.52
Biodesix, Inc. · NASDAQ:BDSXUS$83.83MUS$105.4Mn/a1.0×n/a9.7×−25.7%5.8×1.56
Median of the othersUS$108.1MUS$90.84M32.3×1.3×17.5×2.3×5.5%0.1×1.72

Forecasts

Analysts' consensus from EODHD, read Nov 13, 2026. Not 6ix's view and not investment advice.

Price target
29.50 SEK · Analysts' mean
EPS, year to Dec 2026
-1.14 · 1 analyst
Revenue, year to Dec 2026
1.58B · 2 analysts

Team and board

Officers

OfficerRole
Anders FogelbergPresident and CEO
Jacob ThordenbergChief Financial Officer
Isabelle LjunggrenInvestor Relations
Jesper HagbergChief Operations & Digital Officer

Board

DirectorRole
Erik GatenholmBoard Chair
Christian WildmoserBoard member
Olof StrandingBoard member

Events

Next results
Feb 17, 2027 (expected)

Calls

CallWhenStatus
BICO Group (Stockholm:BICO) Q2 2026 Earnings CallWed, Aug 19, 2026 · 4:00 AM ETReplay
BICO Group (Stockholm:BICO) Q1 2026 Earnings CallWed, Apr 29, 2026 · 4:00 AM ETReplay
BICO Group (Stockholm:BICO) Q4 2025 Earnings CallWed, Feb 18, 2026 · 4:00 AM ETReplay
BICO Group (Stockholm:BICO) Q3 2025 Earnings CallTue, Nov 04, 2025 · 4:00 AM ETReplay
BICO Group (Stockholm:BICO) Q2 2025 Earnings CallTue, Aug 19, 2025 · 4:00 AM ETReplay
BICO Group (Stockholm:BICO) Q1 2025 Earnings CallTue, Apr 29, 2025 · 4:00 AM ETReplay
BICO Group (Stockholm:BICO) Q4 2024 Earnings CallWed, Feb 19, 2025 · 4:00 AM ETReplay
BICO Group (Stockholm:BICO) Q3 2024 Earnings CallTue, Nov 26, 2024 · 4:00 AM ETReplay
BICO Group (Stockholm:BICO) Q2 2024 Earnings CallTue, Aug 20, 2024 · 4:00 AM ETReplay
BICO Group (Stockholm:BICO) Q1 2024 Earnings CallTue, May 07, 2024 · 4:00 AM ETReplay

Results days

QuarterResultsShare move
Q4 2026Nov 11, 2026 · Before open−32.1%
Q3 2026Aug 19, 2026 · Before open+13.2%
Q2 2026Apr 29, 2026 · Before open+10.0%
Q1 2026Feb 18, 2026 · Before open+12.9%
Q4 2025Nov 4, 2025 · Before open+13.8%
Q3 2025Aug 19, 2025 · Before open−22.7%
Q2 2025Apr 29, 2025 · Before open−6.9%
Q1 2025Feb 19, 2025+10.7%
Q4 2024Nov 13, 2024 · After close+0.5%
Q3 2024Aug 20, 2024 · Before open−7.0%
All 20 quarters
QuarterResultsShare move
Q2 2024May 7, 2024 · Before open−17.4%
Q1 2024Feb 20, 2024 · Before open−9.4%
Q4 2023Nov 14, 2023 · Before open+13.8%
Q3 2023Aug 22, 2023 · Before open−0.9%
Q2 2023May 4, 2023 · Before open−8.1%
Q1 2023Feb 22, 2023 · Before open−29.4%
Q4 2022Nov 9, 2022 · Before open+57.4%
Q3 2022Aug 24, 2022 · Before open−0.5%
Q2 2022May 18, 2022 · Before open−3.6%
Q1 2022Feb 23, 2022 · Before open−9.0%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings29 slidesNov 11, 2026
Q2 2026 Earnings PresentationEarnings24 slidesAug 19, 2026
Q1 2026 Earnings PresentationEarnings31 slidesApr 29, 2026
Q4 2025 Earnings PresentationEarnings40 slidesFeb 18, 2026
Q3 2025 Earnings PresentationEarnings36 slidesNov 4, 2025
Q2 2025 Earnings PresentationEarnings26 slidesAug 19, 2025
Q1 2025 Earnings PresentationEarnings27 slidesApr 29, 2025
Q4 2024 Earnings PresentationEarnings30 slidesFeb 19, 2025
43rd Annual J.P. Morgan Healthcare Conference 2025Conference21 slidesJan 15, 2025
Q3 2024 Earnings PresentationEarnings35 slidesNov 26, 2024
All 22 decks
DeckKindSlidesDate
Jefferies Healthcare Conference 2024Conference21 slidesNov 21, 2024
Investor Day (September 2024)Investor day100 slidesSep 17, 2024
Q2 2024 Earnings PresentationEarnings25 slidesAug 20, 2024
Q1 2024 Earnings PresentationEarnings26 slidesMay 7, 2024
JPM Healthcare Conference 2024Conference27 slidesJan 10, 2024
Q3 2022 Earnings PresentationEarnings20 slidesNov 9, 2022
Q2 2022 Earnings PresentationEarnings18 slidesAug 24, 2022
Merger or Acquisition (December 2021)Merger or acquisition18 slidesDec 16, 2021
Cellink — Investor Presentation (March 2021)Investor deck29 slidesMar 10, 2021
Cellink — Investor Day (2021)Investor day98 slides2021
Q4 2019/20 Earnings PresentationEarnings31 slidesOct 22, 2020
Merger or Acquisition (August 2020)Merger or acquisition8 slidesAug 17, 2020

Open Decks

Financings

RaiseDateIn US dollars
Senior secured bonds
Closed: €40M raised · DNB Carnegie
Dealers: DNB Carnegie (lead)
Use of proceeds: General corporate purposes
Jan 28, 2026US$47.77M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in SEK

Income statement

LineFY2025FY2025FY2024FY2024FY2023FY2023FY2022FY2022FY2021FY2021
Revenue1.50B1.50B1.73B1.95B2.01B2.01B2.12B2.24B1.26B1.26B
Cost of revenue716.9M915.3M805.1M939.0M1.02B1.02B408.9M255.0M
Gross profit780.3M581.9M922.1M1.01B993.3M993.2M1.83B1.00B
Research and development204.9M119.4M227.6M354.3M343.2M343.2M
Selling, general and administrative167.3M552.3M542.5M719.0M433.1M
Operating income-1.29B-252.1M-301.1M-289.1M-566.7M-566.7M-274.8M-618.3M-236.9M-160.0M
Depreciation and amortization217.2M478.3M460.4M1.14B289.8M940.6M191.8M191.8M
EBITDA-34.9M189.2M-106.3M577.5M15.0M322.3M-45.1M31.8M
Interest expense322.4M322.4M104.4M97.9M250.9M95.9M187.6M98.2M72.8M59.3M
Income before tax-1.58B-1.58B-81.3M-70.6M-797.3M-797.3M-34.9M-753.1M-213.4M-213.4M
Income tax6.40M6.40M28.7M23.1M-8.60M-8.60M53.2M82.6M15.8M15.8M
Net income-1.09B-1.09B-5.50M-5.50M-1.17B-1.17B-832.9M-835.7M-227.6M-229.2M
Earnings per share, basic-15.43-15.43-0.07-0.08-1,662.00-16.62-1,294.00-12.50-3.97-3.74
Earnings per share, diluted-15.43-0.07-1,662.00-1,294.00-3.97

Balance sheet

LineFY2025FY2025FY2024FY2024FY2023FY2023FY2022FY2022FY2021FY2021
Cash and equivalents1.28B1.28B946.3M598.0M861.0M804.1M925.2M925.2M481.2M481.2M
Short-term investments993.8M
Receivables376.7M429.5M450.7M488.0M520.0M577.6M699.7M1.02B576.9M797.3M
Inventory196.4M196.4M270.5M259.0M427.3M405.2M531.0M493.1M353.5M320.6M
Current assets2.01B2.01B1.85B1.85B2.04B2.04B2.44B2.44B2.65B2.65B
Property, plant and equipment96.1M185.7M241.7M459.8M901.6M209.1M457.6M
Goodwill775.2M2.17B2.09B5.27B5.44B
Total assets3.70B3.70B5.48B5.48B6.06B6.06B10.2B10.2B9.75B9.75B
Accounts payable69.6M69.6M77.9M77.9M170.2M170.2M132.6M132.6M129.1M129.1M
Current liabilities1.57B1.57B570.8M570.8M847.0M847.0M939.5M939.5M730.5M730.5M
Long-term debt200.0K200.0K1.34B1.34B1.42B1.42B1.38B1.38B1.35B1.35B
Total debt200.0K1.50B1.34B1.76B1.42B1.96B1.38B1.85B1.35B1.61B
Total liabilities1.95B1.95B2.48B2.48B2.96B2.96B3.26B3.26B2.95B2.95B
Shareholders' equity1.75B1.75B2.98B2.98B3.07B3.07B6.91B6.91B6.77B6.77B
Shares outstanding70.6M70.6M70.6M66.9M61.4M

Cash flow

LineFY2025FY2025FY2024FY2024FY2023FY2023FY2022FY2022FY2021FY2021
Cash from operations68.4M68.4M158.4M158.4M178.4M178.4M-269.4M-269.4M-409.2M-409.2M
Capital spending-13.3M-13.3M-44.1M-85.7M-171.4M-291.2M-274.1M-529.6M-110.9M-267.0M
Free cash flow55.1M55.1M114.3M72.7M7.00M-112.8M-543.5M-799.0M-520.1M-676.2M
Cash from investing709.3M709.3M128.0M128.0M-129.7M-129.7M212.9M212.9M-4.45B-4.45B
Cash from financing-455.1M-455.1M-200.7M-200.7M-102.0M-102.0M455.3M455.3M4.90B4.90B
Change in cash322.6M335.9M85.7M85.3M-53.3M-64.2M398.8M444.0M37.1M46.3M

Open Financials

Cap table

Built by 6ix from BICO Group AB Class B’s releases · as of Jan 28, 2026

Common shares
69,074,895
Fully diluted
69,074,895

Fully diluted

LineShares
Common shares69,074,895

Share count over time

CountShares
Nov 22, 202669,074,895

Open Cap table

Shareholders

Funds

HolderSharesValueChangeAs of
The 3D Printing ETF1.53MUS$2.31M+505KJul 31, 2026
Avantis International Small Cap Value ETF186KUS$374K+185KMay 31, 2026
Pacer BlueStar Engineering the Future ETF134KUS$203K+120KJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF130KUS$217K−128Jun 30, 2026
State Street(R) SPDR(R) S&P(R) International Small Cap ETF45,489US$75,955+470Jun 30, 2026
The Continental Small Company Series25,357US$38,360No changeJul 31, 2026
Voya Multi-Manager International Small Cap Fund21,964US$33,227NewJul 31, 2026
Avantis International Equity ETF17,241US$34,720No changeMay 31, 2026
World ex U.S. Core Equity Portfolio6,048US$9,149No changeJul 31, 2026
Avantis International Small Cap Equity ETF4,933US$9,934+765May 31, 2026
All 13 holders
HolderSharesValueChangeAs of
Dimensional International Small Cap Value ETF4,490US$6,777No changeJul 31, 2026
State Street(R) SPDR(R) Portfolio Europe ETF1,695US$2,830−39Jun 30, 2026
Avantis International Small Cap Value Fund291US$586No changeMay 31, 2026

Insider trades

InsiderTradeSharesPriceValueDate
Olof Stranding
Member of the Board of Directors
Buy15,000SEK 18.60SEK 279KAug 21, 2026
NavigArt AB
Closely associated with Johan Westman (Member of the Board of Directors)
Buy25,000SEK 20.50SEK 513KApr 29, 2026
Jesper Hagberg
Other member of the company's administrative, management or supervisory body
Buy10,000SEK 21.02SEK 210KApr 29, 2026
Maria Forss
Chief Executive Officer (CEO)/Managing Directory
Buy22,257SEK 21.65SEK 482KApr 29, 2026
Maria Halling Rankka
Chairman of the Board of Directors
Buy11,250SEK 21.90SEK 246KApr 29, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Anders FogelbergPresident and CEO · Since at least Aug 18, 2026
Christian WildmoserBoard member · Since at least May 7, 2026
Erik GatenholmBoard Chair · Since at least Jul 31, 2026
Ewa LinsäterChief Financial Officer · Dec 10, 2025 – Nov 5, 2026 · Past
Isabelle LjunggrenInvestor Relations · Since at least Aug 18, 2026
Jacob ThordenbergChief Financial Officer · Since at least Feb 18, 2026
Jesper HagbergChief Operations & Digital Officer · Since at least Dec 16, 2025
Maria ForssUntil Aug 18, 2026 · Past
Olof StrandingBoard member · Since at least May 7, 2026
Ryan BagleyUntil Aug 18, 2026 · Past

Open People

Log in to ask 6ix AI your own questions about BICO Group AB.